You are here

PCSK9

Novartis’ $9.7B PCSK9 drug nabs first OK — now comes the challenge of finding a market

Endpoints

Fri, 12/11/20 - 11:06 am

Regeneron, Sanofi Strongly Disagree to Jury’s Verdict in Amgen Patent Trial

Bidness, ETC

Wed, 03/16/16 - 07:22 pm

Regeneron, Sanofi Take Step Forward With Cholesterol Drug

Minyanville

Mon, 11/5/12 - 11:05 am

LDL cholesterol

SAR236553/REGN727

Next big drug against cholesterol takes shape

HealthNews

Sat, 08/27/11 - 01:35 pm

hypercholesterolemia

Bristol-Myers Squibb